Worth reading
39Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Announced details
Applicable field (uses covered by this announcement)
IR presentation for individual investors
Launch date15 September 2026 (scheduled)
Relationship between the counterparty and the company
K Pharma,Inc.4896
Relationship with the Company
株式会社日本証券新聞社 is the organizer, and グロース・キャピタル株式会社 is the co-organizer.
Counterparty株式会社日本証券新聞社, グロース・キャピタル株式会社
株式会社日本証券新聞社: not disclosed, グロース・キャピタル株式会社: not disclosed
Location (as indicated in this announcement)
Tokyo Securities Kaikan, 8th-floor hall (1-5-8 Nihonbashi-Kayabacho, Chuo-ku, Tokyo)
Offering price
Admission fee: Free
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Counterparty | 株式会社日本証券新聞社, グロース・キャピタル株式会社 |
| Counterparty overview | 株式会社日本証券新聞社: not disclosed, グロース・キャピタル株式会社: not disclosed |
| Relationship with the Company | 株式会社日本証券新聞社 is the organizer, and グロース・キャピタル株式会社 is the co-organizer. |
| Offering price | Admission fee: Free |
| Launch date | 15 September 2026 (scheduled) |
| Applicable area | IR presentation for individual investors |
| Location | Tokyo Securities Kaikan, 8th-floor hall (1-5-8 Nihonbashi-Kayabacho, Chuo-ku, Tokyo) |
Items this document does not state (11)
Names of Products / Services CoveredContract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To provide an opportunity to explain the Company's corporate philosophy, business progress and growth strategy directly to individual investors.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.